Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

358
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
358
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.3K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

354
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

427
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
427
Angina IV: Management01:26

Angina IV: Management

368
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

590
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
590

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk Stratification Methods, Use Cases, and Lessons Learned.

Family practice management·2025
Same author

Creating Patient Safety Team Members Through a Simulation-Based Interprofessional Root Cause Analysis Course.

Journal of graduate medical education·2022
Same author

Development of an international standard set of patient-centred outcome measures for overall paediatric health: a consensus process.

Archives of disease in childhood·2020
Same author

Adopting RCA<sup>2</sup>: The Interrater Reliability of Safety Assessment Codes.

American journal of medical quality : the official journal of the American College of Medical Quality·2018
Same author

Leveraging Health Information Technology to Improve Quality in Federal Healthcare.

U.S. Army Medical Department journal·2015
Same author

Diagnosis and Management of Foodborne Illness.

American family physician·2015

Related Experiment Video

Updated: Mar 6, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.9K

Acute Coronary Syndrome: Current Treatment.

Timothy L Switaj1, Scott R Christensen2, Dean M Brewer3

  • 1U.S. Army Medical Department Center and School, Fort Sam Houston, TX, USA.

American Family Physician
|March 15, 2017
PubMed
Summary

Family physicians must quickly identify acute coronary syndrome (ACS) risk factors and symptoms. Prompt diagnosis and reperfusion therapy, like percutaneous coronary intervention, improve patient outcomes and prevent mortality.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.7K
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.9K

Related Experiment Videos

Last Updated: Mar 6, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.9K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.7K
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.9K

Area of Science:

  • Cardiology
  • Family Medicine
  • Emergency Medicine

Background:

  • Acute coronary syndrome (ACS) remains a leading cause of death and disability in the US.
  • Early identification and management of ACS are critical for family physicians.
  • Effective risk factor mitigation and prompt response to ACS events are essential in all clinical settings.

Purpose of the Study:

  • To outline the diagnostic criteria for acute coronary syndrome.
  • To detail the recommended management strategies for ST-elevation myocardial infarction (STEMI) and non-ST-elevation ACS.
  • To emphasize the importance of secondary prevention post-myocardial infarction.

Main Methods:

  • Diagnosis relies on patient history, symptoms, electrocardiography (ECG), and cardiac biomarkers.
  • Delineation between ST-elevation myocardial infarction (STEMI) and non-ST-elevation ACS is crucial for treatment selection.
  • Treatment strategies include primary percutaneous coronary intervention (PCI), fibrinolytic therapy, and medical management.

Main Results:

  • Primary PCI is the preferred reperfusion strategy for STEMI.
  • Fibrinolytic therapy is an alternative for STEMI if PCI is delayed.
  • Medical management is recommended for low-risk non-STEMI patients or when PCI is not feasible.

Conclusions:

  • Timely reperfusion therapy significantly improves outcomes for myocardial infarction.
  • Comprehensive secondary prevention strategies are vital to reduce recurrence and mortality.
  • Coordinated care between family physicians and cardiologists is essential for post-MI management.